Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.
about
Chronic granulomatous diseaseResidual NADPH oxidase and survival in chronic granulomatous diseaseSuccessful hepatectomy for hepatic abscess with chronic granulomatous disease: a case report.Chronic granulomatous disease: a review of the infectious and inflammatory complications.Chronic granulomatous disease: overview and hematopoietic stem cell transplantationCommon severe infections in chronic granulomatous diseaseCorticosteroid therapy for liver abscess in chronic granulomatous disease.Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency.Infections associated with chronic granulomatous disease: linking genetics to phenotypic expression.Recent advances in transplantation for primary immune deficiency diseases: a comprehensive review.Pathology of the liver sinusoids.Chronic Granulomatous Disease in Patients Reaching Adulthood: A Nationwide Study in France.Liver injury is associated with mortality in sickle cell disease.Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo.Ataxia telangiectasia associated with nodular regenerative hyperplasiaIdiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study.A Review of Chronic Granulomatous Disease.NADPH Oxidase Deficiency: A Multisystem Approach.Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity.
P2860
Q27009322-7BC212D8-A2CA-4B80-AAD8-7C89E023ED7DQ28301969-8D546BC4-18AA-4976-8258-5308A69FEC80Q33606830-A60866B8-460E-4819-8A63-12A3DEC4C98FQ35084276-762954A5-A044-4CD8-99CA-F953E69261FAQ35098193-F2F096A7-B561-4500-BE9F-02A09657B80AQ35451854-38272B3C-2B2B-4FBA-9FD4-7BFF44C49B94Q35745685-C96368D1-A79E-4A4B-AA6C-38870F522FDCQ37238684-F625709A-1ACB-4386-AD2E-09C61113F392Q38048847-D3F692AD-66BE-4F9A-9532-DB26683546B2Q38119863-77CB67A0-273F-4628-B7EA-BC8293DF5BBCQ38176084-04CE02A5-32AA-4B09-9D94-B89B6F8686CAQ40270325-4F70F524-A9F5-4F05-9B14-24A01FC30DE6Q41076119-A023A6E6-69AD-40C5-8851-69D616D87F83Q42084575-DD71F3B9-E4A0-41BC-8DD3-4583A82FD00DQ42735285-A91528E1-4F9F-4A3D-BCC6-75AB20DA6C3BQ45216579-D0E7661B-74C1-43AE-86E0-5230D1A702D3Q45874911-DF70BF1E-D08B-45F5-B295-946BB2D98308Q49422978-18D8B3AD-B90B-4D8F-ACE4-9DEE4784CE93Q50717522-2EA768A1-31ED-4758-B45B-BD33087AA9EF
P2860
Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Hepatic involvement and portal ...... chronic granulomatous disease.
@ast
Hepatic involvement and portal ...... chronic granulomatous disease.
@en
type
label
Hepatic involvement and portal ...... chronic granulomatous disease.
@ast
Hepatic involvement and portal ...... chronic granulomatous disease.
@en
prefLabel
Hepatic involvement and portal ...... chronic granulomatous disease.
@ast
Hepatic involvement and portal ...... chronic granulomatous disease.
@en
P2093
P2860
P1433
P1476
Hepatic involvement and portal ...... chronic granulomatous disease.
@en
P2093
Dianne Hilligoss
Elizabeth C Wright
Jay H Hoofnagle
John I Gallin
Jordan J Feld
Nadeem Hussain
Steven M Holland
Sushil Ahlawat
T Jake Liang
Theo Heller
P2860
P304
P356
10.1053/J.GASTRO.2008.02.081
P407
P577
2008-03-04T00:00:00Z